⚕ GalenOps CRO console
← 701 (USA)

701-1097

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2014-01-01
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-21 (study day 52.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-21 (study day 52.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE VESICLES — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 51.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-03 (study day 3.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: NONE

mild assessed 2026-08-18

Mild PHARYNGOLARYNGEAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: NONE

moderate assessed 2026-08-18

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 51.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-03-21 (study day 80.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-03-31 (study day 90.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.